CHAMPAIGN, IL / ACCESS Newswire / April 22, 2025 / BioLumic Inc., a pioneer in seed trait innovation, today announced the close of its oversubscribed Series B Extension, securing $8.3 million USD from new and existing investors, including Ki Tua Fund, Azolla Ventures, and iSelect Fund. The new capital will accelerate the commercial growth of a breakthrough category of seed traits – xTraits™ – the world’s first seed traits activated purely by precise light signals.

Read more here.